Journey Medical Corp
NASDAQ:DERM

Watchlist Manager
Journey Medical Corp Logo
Journey Medical Corp
NASDAQ:DERM
Watchlist
Price: 5.37 USD 3.27% Market Closed
Market Cap: 107.4m USD
Have any thoughts about
Journey Medical Corp?
Write Note

Relative Value

The Relative Value of one DERM stock under the Base Case scenario is 3.75 USD. Compared to the current market price of 5.37 USD, Journey Medical Corp is Overvalued by 30%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

DERM Relative Value
Base Case
3.75 USD
Overvaluation 30%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
15
vs Industry
64
Median 3Y
0.9
Median 5Y
0.9
Industry
2.5
Forward
1.8
vs History
7
vs Industry
Median 3Y
-1.4
Median 5Y
-1.4
Industry
21.9
Forward
-4.5
vs History
vs Industry
4
Median 3Y
-2.5
Median 5Y
-2.5
Industry
16.5
vs History
7
vs Industry
30
Median 3Y
-3.4
Median 5Y
-3.4
Industry
23.6
vs History
7
vs Industry
8
Median 3Y
2.3
Median 5Y
2.3
Industry
2.1
vs History
7
vs Industry
66
Median 3Y
0.6
Median 5Y
0.6
Industry
2.6
Forward
1.8
vs History
7
vs Industry
72
Median 3Y
1.1
Median 5Y
1.1
Industry
5.2
vs History
21
vs Industry
2
Median 3Y
-0.8
Median 5Y
-0.8
Industry
13.3
Forward
177.8
vs History
15
vs Industry
7
Median 3Y
-1.1
Median 5Y
-1.1
Industry
16.6
Forward
-5.1
vs History
vs Industry
5
Median 3Y
-1.6
Median 5Y
-1.6
Industry
15.6
vs History
vs Industry
5
Median 3Y
-1.2
Median 5Y
-1.2
Industry
19.1
vs History
10
vs Industry
22
Median 3Y
1.4
Median 5Y
1.4
Industry
1.9

Multiples Across Competitors

DERM Competitors Multiples
Journey Medical Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Journey Medical Corp
NASDAQ:DERM
107.5m USD 1.4 127.4 19.2 48.5
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
US
Journey Medical Corp
NASDAQ:DERM
Average P/E: 44.3
127.4
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top